Home > Compound List > Compound details
171599-83-0 molecular structure
click picture or here to close

2-hydroxypropane-1,2,3-tricarboxylic acid; 5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one

ChemBase ID: 72676
Molecular Formular: C28H38N6O11S
Molecular Mass: 666.69992
Monoisotopic Mass: 666.23192707
SMILES and InChIs

SMILES:
c1(ccc(c(c1)c1nc2c(c(=O)[nH]1)n(nc2CCC)C)OCC)S(=O)(=O)N1CCN(CC1)C.C(C(=O)O)C(CC(=O)O)(O)C(=O)O
Canonical SMILES:
OC(=O)CC(C(=O)O)(CC(=O)O)O.CCCc1nn(c2c1nc([nH]c2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)C)C
InChI:
InChI=1S/C22H30N6O4S.C6H8O7/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28;7-3(8)1-6(13,5(11)12)2-4(9)10/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
InChIKey:
DEIYFTQMQPDXOT-UHFFFAOYSA-N

Cite this record

CBID:72676 http://www.chembase.cn/molecule-72676.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
2-hydroxypropane-1,2,3-tricarboxylic acid; 5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one
IUPAC Traditional name
citro; sildenafil
citric acid; sildenafil
Synonyms
Viagra
Revatio
Sildenafil citrate
1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate salt
5-[2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[5,4-e]pyrimidin-7-one citrate salt
UK-92,480
Sildenafil citrate salt
1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine Citrate
CAS Number
171599-83-0
MDL Number
MFCD09026931
PubChem SID
162037597
PubChem CID
62853

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 7.6270576  H Acceptors
H Donor LogD (pH = 5.5) 0.7387564 
LogD (pH = 7.4) 1.158596  Log P 1.229504 
Molar Refractivity 139.8739 cm3 Polarizability 48.292347 Å3
Polar Surface Area 109.13 Å2 Rotatable Bonds 11 
Lipinski's Rule of Five false 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Solubility
DMSO expand Show data source
DMSO: >20 mg/mL expand Show data source
Apperance
white powder expand Show data source
White Solid expand Show data source
Melting Point
187-189°C expand Show data source
Storage Condition
-20°C expand Show data source
-20°C Freezer expand Show data source
Storage Warning
Store in Freezer expand Show data source
European Hazard Symbols
Irritant Irritant (Xi) expand Show data source
MSDS Link
Download expand Show data source
Download expand Show data source
German water hazard class
3 expand Show data source
Risk Statements
36/37/38 expand Show data source
Safety Statements
36 expand Show data source
GHS Pictograms
GHS07 expand Show data source
GHS Signal Word
Warning expand Show data source
GHS Hazard statements
H315-H319-H335 expand Show data source
GHS Precautionary statements
P261-P305 + P351 + P338 expand Show data source
Storage Temperature
room temp expand Show data source
Target
PDE expand Show data source
Purity
≥98% (HPLC) expand Show data source
97% expand Show data source
Salt Data
Citrate expand Show data source
Certificate of Analysis
Download expand Show data source
Empirical Formula (Hill Notation)
C22H30N6O4S ·C6H8O7 expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals Sigma Aldrich Sigma Aldrich TRC TRC
Selleck Chemicals - S1431 external link
Research Area: Cardiovascular Disease
Biological Activity:
Sildenafil citrate is an agent used to treat erectile dysfunction and pulmonary arterial hypertension (PAH). It acts by inhibiting cGMP specific phosphodiesterase type 5, an enzyme that regulates blood flow in the penis. Sildenafil has been the prime treatment for erectile dysfunction. [1]
Sigma Aldrich - PZ0003 external link
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Sildenafil is a potent, selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5). Sildenafil is used to treat erectile dysfunction and pulmonary arterial hypertension. NO activates guanylate cyclase, which results in increased levels of cGMP, producing smooth muscle relaxation. Sildenafil enhances the effect of NO by inhibiting PDE5, which is responsible for degradation of cGMP.
Toronto Research Chemicals - S435000 external link
An orally active selective type 5 cGMP phosphodiesterase inhibitor.

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • •  http://en.wikipedia.org/wiki/Sildenafil_citrate
  • • Terrett, N.K., et al.: Bioorg. Med. Chem. Lett., 6, 1819 (1996)
  • • Goldstein, I., et al.: N. Engl. J. Med., 338, 1397 (1996)
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle